Previous Page  9 / 14 Next Page
Information
Show Menu
Previous Page 9 / 14 Next Page
Page Background

Endocrinology 2018

Journal of Clinical and Molecular Endocrinology

ISSN: 2572-5432

Page 28

August 09-10, 2018

Madrid, Spain

11

th

International Conference on

Endocrinology and

Diabetology

T

he misdiagnosis of diabetes remains a significant problem

for the endocrinologist. The author will speak about

‘neuroregulation’, in particular the neuroregulation of blood

glucose levels i.e. that blood glucose is a neurally regulated

physiological system, that diabetes can occur in patients who

have a normally functioning pancreas, and that T1DM and

T2DM invariably occur as comorbidities. It is inevitable that

diabetes must be BOTH type 1 and type 2 diabetes. Type 1 is

the genetic condition which is followed by the process by which

the expressed insulin reacts with its reactive substrate IRP2. The

problemof type 3 diabetes – themulti-systemic chronic condition

- is an advanced complication of the condition. Accordingly, an

inexpensive test is required which is able to determine the rate

of genetic expression of pre-pro-insulin/insulin (type 1), which

can determine the rate at which the expressed insulin reacts

with its reactive substrate (type 2), and which can determine the

complex pathological correlates of the condition (type3). This is

an enormous problem for the medical profession. To screen for

the range of complex correlates using contemporary biomedical

indices will add immense cost to the diagnostic process however

there is one technology - Strannik Virtual Scanning –which is able

to do so at much lower cost than any current technology(s).

Biography

Graham Ewing

B.Sc

. is author of ca 80 articles which have been published

in peer-reviewed medical journals and/or have been presented at medical

conferences. He has a current rating of 15.83 on ResearchGate which plac-

es him in the upper 40% of researchers. His work is immensely popular. This

presentation focuses upon a dominant theme of his work, that cognitive

changes reflect pathological onset and can be used as the basis of a math-

ematical model of how the brain regulates the autonomic nervous system

and physiological systems; and how this can be used to screen and treat the

health of the patient. The presentation focuses upon diabetes – primarily

because changes of colour perception accompany the onset of diabetes

and can be used to explain and determine the complex correlates of what

has come to be known as diabetes mellitus but which is in reality a far more

complex phenomena.

graham.ewing@mmhcl.co.uk

Blood Glucose is Neurally Regulated

Graham Ewing

Mimex Montague Healthcare, UK

Graham Ewing, J Clin Mol Endocrinol 2018, Volume 3

DOI: 10.21767/2572-5432-C2-005